Press Releases May 1, 2026 08:00 AM

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Health Catalyst schedules Q1 2026 earnings release and conference call for May 11, 2026

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
HCAT

Health Catalyst, a healthcare intelligence company listed on Nasdaq as HCAT, announced it will release its first quarter 2026 operating results after market close on May 11, 2026, followed by a conference call to discuss the results. The company specializes in AI-driven healthcare data analytics aimed at improving health system performance.

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026
HCAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Health Catalyst will announce Q1 2026 operating results on May 11, 2026.
  • The company will host a conference call and webcast to discuss the results.
  • Health Catalyst provides AI-driven healthcare intelligence to improve health system cost, clinical, and consumer outcomes.

SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.

Conference Call Details

The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID “HCATQ126.” A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Health Catalyst

Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action.

Health Catalyst Investor Relations Contact:

Stephanie St. Clair
Finance and Investor Relations, SVP
ir@healthcatalyst.com

Health Catalyst Media Contact:

‍Kathryn Larson
Director of Public Relations and Communications
media@healthcatalyst.com


Risks

  • Operational results may fall short of investor expectations, potentially impacting stock price.
  • Market conditions in the healthcare and technology sectors could affect the company's performance.
  • Reliance on AI and data technology adoption in healthcare systems poses integration and scalability risks.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026